Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow Doppler: Study in different phases of sequential therapy

Fertility and Sterility

Volumn 71, Issue 3, 1999, Pages 536-543

  Exacoustòs, Caterina ^a   Lello, Stefano ^a   Caporale, Elisabetta ^a   Minghetti, Maria Carla ^a   Angelozzi, Donatella ^a   Arduini, Domenico ^a   Romanini, Carlo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Dydrogesterone; Endometrial thickness; Hormone replacement therapy; Pulsatility index; Transvaginal color flow Doppler; Uterine arteries

Indexed keywords

DYDROGESTERONE; EPIESTROL; ESTRADIOL; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE; UNCLASSIFIED DRUG;

ADULT; ARTERY DILATATION; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; HORMONE SUBSTITUTION; HUMAN; ITALY; PATIENT MONITORING; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSDERMAL DRUG ADMINISTRATION; TRANSVAGINAL ECHOGRAPHY; UTERINE ARTERY; UTERUS BLOOD FLOW;

AGED; DYDROGESTERONE; ENDOMETRIUM; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; ULTRASONOGRAPHY, DOPPLER, COLOR; UTERUS;

EID: 0032938153     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00481-6     Document Type: Article

References (44)

1. Speroff L. The effect of oestrogen-progestogen postmenopausal hormone replacement therapy on the cardiovascular system. Eur Menopause J. (3 Suppl):1996;151-163.
2. Cheang A., Sitruk-Ware R., Samsioe G. Transdermal oestradiol and cardiovascular risk. Br J Obstet Gynaecol. 101:1994;571-581.
3. Vyas S., Gangar K. Postmenopausal oestrogens and arteries. Br J Obstet Gynaecol. 102:1995;942-946.
4. Bergqvist A., Bergqvist D., Ferno M. Estrogen and progesterone receptors in vessel walls biochemical and immunochemical assays . Acta Obstet Gynecol Scand. 72:1993;10-16.
5. Perrot-Applanat M., Groyer-Picard M.T., Garcia E., Lorenzo F., Milgrom E. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology. 123:1988;1511-1519.
6. Gangar K.F., Vyas S., Whitehead M.I., Crook D., Meier H., Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 338:1991;839-842.
7. Penotti M., Nencioni T., Gabrielli L., Farina M., Castiglioni E., Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am J Obstet Gynecol. 169:1993;1226-1232.
8. Bourne T.H., Hillard T., Whitehead M., Crook D., Campbell S. Oestrogen, arterial status, and postmenopausal women. Lancet. 335:1990;1470-1471.
9. Rubin C.L., Peterson H.B., Lee N.C., Maes E.F., Wingo P.A., Becker S. Estrogen replacement therapy and the risk of endometrial cancer remaining controversies . Am J Obstet Gynecol. 162:1990;148-154.
10. Woodruff J.D., Pickar J.H. Incidence of endometrial hyperplasia in post-menopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Am J Obstet Gynecol. 170:1994;1213-1223.
11. Whitehead M.I., Hillard T.C., Crook D. The role and use of progestogens. Obstet Gynecol. 75:(4 Suppl):1990;59S-76S.
12. Gambrell R.D. Jr. Use of progestogens in postmenopausal women. Int J Fertil. 34:1989;315-321.
13. Voigt L.F., Weiss N.S., Chu J., Daling J.R., McKight B., Van Gelle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet. 338:1991;274-277.
14. Bourne T.H., Hillard T., Whitehead M., Campbell S., Collins W.P. Transvaginal ultrasonograpy with colour flow imaging to monitor hormone replacement therapy in postmenopausal women. Br J Radiol. 64:1991;657-661.
15. Hillard T.C., Bourne T.H., Whitehead M.I., Crayford T.B., Collins W.P., Campbell S. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil Steril. 58:1992;959-963.
16. Marsh M.S., Bourne T.H., Whitehead M.I., Collins W.P., Campbell S. The temporal effect of progestogen on uterine pulsatility index in postmenopausal women receiving sequential hormone replacement therapy. Fertil Steril. 62:1994;771-774.
17. Pirhonen J.P., Vuento M.H., Mäkinen J.I., Salmi T.A. Long-term effects of hormone replacement therapy on the uterus and on uterine circulation. Am J Obstet Gynecol. 168:1993;620-623.
18. Järvelä I., Raudaskoski T., Tekay A., Jouppila P. Effect of the levonorgestrel-releasing intrauterine system on the uterine artery pulsatility index in postmenopausal hormone replacement therapy. Ultrasound Obstet Gynecol. 10:1997;350-355.
19. Steer C.V., Campbell S., Pampiglione J., Kingsland C., Mason B.A., Collins W.P. Transvaginal color flow imaging of uterine arteries during ovarian and menstrual cycles. Hum Reprod. 5:1990;391-395.
20. Bourne T.H. Transvaginal color Doppler in gynecology. Ultrasound Obstet Gynecol. 5:1991;359-373.
21. Sladkevicius P., Valentin L., Marsal K. Blood velocity in the uterine and ovarian arteries during the normal menstrual cycle. Ultrasound Obstet Gynecol. 3:1993;199-207.
22. Lobo R.A. The role of progestins in hormone replacement therapy. Am J Obstet Gynecol. 166:1992;1997-2004.
23. Rozebaum H. Relationship between chemical structure and biological properties of progestogens. Am J Obstet Gynecol. 142:1982;719-724.
24. Balfour J.A., Heel R.C. Transdermal estradiol a review of its pharmacodynamic and pharmakocinetic properties, and therapeutic efficacy in the treatment of menopausal complaints . Drugs. 40:1990;561-582.
25. Padwick M.L., Pryse-Davies J., Whitehead M.I. A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens. N Engl J Med. 315:1986;930-934.
26. Sturdee D.W., Barlow D.H., Urlich L.G., Wells M., Gydesen H., Campbell M., et al. Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestogen replacement therapy? Lancet. 343:1994;979-982.
27. Granberg S., Bourne T.H., Wikland M., Hahlin M., Gull B., Karlson B. Transvaginal sonography of endometrial disorders in postmenopausal women. Fleischer A.C., Kurjak A., Granberg S. Ultrasound and the endometrium. 1997;29-46 Parthenon, New York.
28. Fleischer A.C., Appelbaum M.I., Parsons A.K. Transvaginal sonography of the normal endometrium. Fleischer A.C., Kurjak A., Granberg S. Ultrasound and the endometrium. 1997;1-15 Parthenon, New York.
29. Osmers R. Transvaginal sonography in endometrial cancer. Ultrasound Obstet Gynecol. 2:1992;2-3.
30. Parson A.K. Evaluation of postmenopausal endometrium. Ultrasound Obstet Gynecol. 12:1998;295-300.
31. Whitehead M.I., Townsend P.T., Pryse-Davies J., Ryder T.A., King R.J.B. Effect of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med. 305:1981;1599-1604.
32. Gurpide E., Tseng L., Busbery S.B. Estrogen metabolism in normal and neoplastic endometrium. Am J Obstet Gynecol. 129:1977;809-816.
33. Mendelsohn M.E., Karas R.H. Estrogen and the blood vessel wall. Curr Opin Cardiol. 9:1994;619-626.
34. Mikkola T., Turunen P., Avela K., Orpana A., Viinikka L., Ylikorkala O. 17 Beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab. 80:1995;1832-1836.
35. Jiang C., Sarrel P.M., Poole-Wilson P.A., Collins P. Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol. 263:(1 Pt 2):1992;H271-H275.
36. Weiner C.P., Lizasoain I., Baylis S.A., Knowles R.G., Charles I.G., Moncada S. Induction of calcium-dependent nitric oxide syntheses by sex hormones. Proc Natl Acad Sci USA. 91:1994;5212-5216.
37. 2+ uptake of uterine arterial smooth muscle cells through potential-sensitive channels. Biol Reprod. 36:1987;361-368.
38. Penotti M., Sironi L., Miglierina L., Farina M., Barletta L., Gabrielli L., et al. The effect of tamoxifen and transdermal 17β-estradiol on cerebral arterial vessels a randomized controlled study . Am J Obstet Gynecol. 178:1998;801-805.
39. De Ziegler D., Bessis R., Frydman R. Vascular resistance of uterine arteries physiological effects of estradiol and progesterone . Fertil Steril. 55:1991;775-779.
40. Bonilla-Musoles F., Marti M.C. Effect of hormone replacement therapy on uterine blood flow and endometrial status in postmenopausal women. Fleischer A.C., Kurjak A., Granberg S. Ultrasound and the endometrium. 1997;97-108 Parthenon, New York.
41. Tinkanen H., Kujansuun E., Laippala P. The association between hormonal levels and vascular resistance in uterine and ovarian arteries in spontaneous menstrual cycles - a Doppler ultrasound study. Acta Obstet Gynecol Scand. 74:1975;297-301.
42. Persson I., Adami H.O., Lindberg B.S., Johansson E.D.B., Manel P. Characteristics of estrogen-treated women. Acta Obstet Gynecol Scand. 62:1983;297-302.
43. Ylikorkala O., Puolakkala J., Viinikka L. Vasoconstrictory thromboxane A2 and vasodilatory prostacyclin in climacteric women effect of oestrogen-progestogen therapy . Maturitas. 5:1984;201-205.
44. Miller V.M., Vanhoutte P.M. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 261:(4 Pt 2):1991;R1022-R1027.